하악신경 절삭이 삼차신경절 신경세포와 연수후각 소교세포 활성화에 미치는 영향
Effects of mandibular nerve transection on trigeminal ganglion neurons and the activation of microglial cells in the medullary dorsal horn
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Microglial cell activation is known to contribute to neuropathic pain following spinal sensory nerve injuries. In this study, I investigated its mechanisms in the case of trigeminal sensory nerve injuries by which microglial cell and p38 mitogen-activated protein kinase (p38 MAPK) activation in the medullary dorsal horn (MDH) would contribute to the facial pain hypersensitivity following mandibular nerve transection (MNT). And also investigated the changes of trigeminal ganglion neurons and ERK, p38 MAPK manifestations. Activation of microglial cells was monitored at 1, 3, 7, 14, 28 and 60 day using immunohistochemical analyses. Microglial cell activation was primarily observed in the superficial laminae of the MDH. Microglial cell activation was initiated at postoperative 1 day, maximal at 3 day, maintained until 14 day and gradually reduced and returned to the basal level by 60 days after MNT. Pain hypersensitivity was also initiated and attenuated almost in parallel with microglial cell activation pattern. To investigate the contribution of the microglial cell activation to the pain hypersensitivity, minocycline, an inhibitor of microglial cell activation by means of p38 MAPK inhibition, was administered. Minocycline dose-dependently attenuated the development of the pain hypersensitivity in parallel with inhibition of microglial cell and p38 MAPK activation following MNT. Mandibular nerve transection induced the activation of ERK, but did not p38 MAPK in the trigeminal ganglion. These results suggest that microglial cell activation in the MDH and p38 MAPK activation in the hyperactive microglial cells play an important role in the development of facial neuropathic pain following MNT. The results also suggest that ERK activation in the trigeminal ganglion contributes microglial cell activation and facial neuropathic pain.
참고문헌 (28)
- "Deafferentation pain after posterior rhizotomy trauma to a limb", pp.928~932
- "Treatment of trigeminal neuralgia", 334, pp.1125~1126 (1996)
- "Beyond neurons: evidence that immune and glial cells contribute to pathological pain states", 82, pp.981~1011 (2002)
- "Glia: a novel drug discovery target for clinical pain", 2, pp.973~985 (2003)
- "ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model", 114, pp.149~159 (2005)
- "Staining of glial fibrillary acidic protein in lumbar spinal cord increases following a sciatic nerve constriction injury", pp.1~7
- "GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801", pp.237~243
- "Microglial reactions after subcutaneous formalin injection into the rat hind paw", 825, pp.59~67 (1999)
- "Microglia and the early phase of immune surveillance in the axotomized facial motor nucleus: impaired microglial activation and lymphocyte recruitment but no effect on neuronal survival or axonal regeneration in macrophage-colony stimulating factor-deficient mice", 436, pp.182~201 (2001)
- "p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain", 23, pp.4017~4022 (2003)
- "P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury", 424, pp.778~783 (2003)
- "Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury", 45, pp.89~95 (2004)
- "Neuropathic pain and spinal microglia: a big problem from molecules in ‘small’glia", 28, pp.101~107 (2005)
- "Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson’s disease", 98, pp.14669~14674 (2001)
- "Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia", 21, pp.2580~2588 (2001)
- "Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia", 166, pp.7527~7533 (2001)
- Watkins LR, "Glial activation: a driving force for pathological pain", 24, pp.450~455 (2001)
- Zimmermann M, "Ethical guidelines for investigations of experimental pain in conscious animals", pp.109~110
- Yrjanheikki J, "Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia", 95, pp.15769~15774 (1998)
- Wu DC, "Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease", 22, pp.1763~1771 (2002)
- Zhu S, "Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice", 417, pp.74~78 (2002)
- Raghavendra V, "Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy", 306, pp.624~630 (2003)
- Zhang SC, "Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors", 41, pp.191~198 (2003)
- Colburn RW, "Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat", 79, pp.163~175 (1997)
- Kreutzberg GW, "Microglia: a sensor for pathological events in the CNS", 19, pp.312~318 (1996)
- Sweitzer SM, "Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat", 829, pp.209~221 (1999)
- Wieseler-Frank J, "Glial activation and pathological pain", 45, pp.389~395 (2004)
- Obata K, "Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation", 24, pp.10211~10222 (2004)